CVS Health is expected to report a 6.5% year-over-year increase in fourth-quarter revenues, driven by a 4% rise in total prescription counts and the opening of 120 new pharmacy locations across six states. The company’s integrated pharmacy benefit management unit processed 210 million prescriptions during the quarter, up from 202 million in the prior year period. Management cited increased utilization of specialty medications, which now account for 12% of total scripts, as a key contributor to higher gross margins in its Pharmacy and Consumer Wellness segment.

Following its early restructuring efforts, CVS Health reported a 2.3 point expansion in adjusted operating margin for the nine months ended December 31, driven by $650 million in annualized cost savings. The company reduced overhead expenses by consolidating three regional distribution centers and renegotiating contracts with major PBM clients. As a result, SG&A expenses fell to 12% of revenues, compared with 14% a year ago. Analysts expect these efficiency gains to further support EBITDA growth of 8% in the upcoming fiscal year.

In its most recent 13F filing, Strengthening Families & Communities LLC disclosed a purchase of 30,090 additional shares, bringing its total holding to 31,654 shares valued at $2.37 million. Other notable positions established or increased during the third quarter include QRG Capital Management’s 92,896 shares (up 173.9%) and Hilltop National Bank’s new stake of approximately 1,200 shares. Institutional ownership now represents 80.7% of total shares outstanding, underscoring broad investor confidence in CVS Health’s long-term cash flow generation and dividend sustainability.